谷歌浏览器插件
订阅小程序
在清言上使用

REGISTRI: Regorafenib in First-Line of KIT/PDGFRA Wild Type Metastatic GIST: a Collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) Phase II Trial

Molecular Cancer(2023)

引用 4|浏览7
关键词
Wild type GIST,SDH,Regorafenib,Biomarker,Clinical trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要